Cargando…
Antiangiogenic therapies in ovarian cancer
Angiogenesis plays a pivotal role in normal ovarian physiology as well as in the formation and progression of ovarian cancer. Several well-designed phase II and III trials studied the efficacy of antiangiogenic agents in advanced ovarian cancer. The results of these trials demonstrated significantly...
Autor principal: | Reinthaller, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045478/ https://www.ncbi.nlm.nih.gov/pubmed/27752291 http://dx.doi.org/10.1007/s12254-016-0282-4 |
Ejemplares similares
-
Novel concepts of antiangiogenic therapies in metastatic renal cell cancer
por: Pichler, Renate, et al.
Publicado: (2017) -
Antiangiogenic Cancer Therapy
por: Maxwell, P H, et al.
Publicado: (2009) -
Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy
por: Jin, Chengwen, et al.
Publicado: (2022) -
Antiangiogenic drugs in ovarian cancer
por: Kumaran, G C, et al.
Publicado: (2009) -
Antiangiogenic therapy for breast cancer
por: Nielsen, Dorte Lisbet, et al.
Publicado: (2010)